People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Artax Biopharma, Inc. | — | Biotechnology | Series B | $48.0M | $75.7M | 2024 |
| Avila Therapeutics Inc | — | Biotechnology | Series B | $45.0M | $893.0M | 2009 |
| Zikani Therapeutics, Inc. | — | Pharmaceuticals | Series A | $31.7M | $232.3M | 2018 |
| Arrakis Therapeutics, Inc. | — | Biotechnology | Series A | $28.2M | $542.3M | 2017 |
| Pranalytica Inc | — | Other Technology | Seed | $1.5M | $7.7M | 2015 |
Raj Parekh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Raj Parekh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Henry Skinner | 2 | 4 |
| Alan E. Walts | 2 | 3 |
| Amir Nashat | 1 | 14 |
| Bruce Booth | 1 | 12 |
| Peter B. Finn | 1 | 11 |
| Lawrence Miller | 1 | 8 |
| Richard Gaster | 1 | 7 |
| Daniel Lynch | 1 | 7 |
| Joseph Zakrzewski | 1 | 6 |
| Michael Gilman | 1 | 6 |
| Vicki Sato | 1 | 6 |
| Gino Santini | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| Casper Breum | 1 | 5 |
| Katrine Bosley | 1 | 4 |
| Markus Goebel | 1 | 4 |
| Andrew Myers | 1 | 4 |
| Nikola Trbovic | 1 | 3 |
| Gino W. Santini | 1 | 3 |
| Alan Walts | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.